- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips open 1T goes commercial
Images obtained using the new Panorama 1T open MR scanner equal or surpass the quality of cylindrical 1.5T systems, according to developer Philips Medical Systems. The first of this breed of scanner began operating in mid-October at a Las Vegas outpatient clinic owned by Nevada Imaging Centers. It is not the first open 1T to enter clinical service; Siemens Medical Solutions has installed three 1T Rhapsody systems at clinical sites. The Panorama 1T, however, is the only truly high-field open MR designed for mass production. Routine deliveries of the system, which was shown at this year's RSNA meeting, are scheduled to begin in 2005.
Images obtained using the new Panorama 1T open MR scanner equal or surpass the quality of cylindrical 1.5T systems, according to developer Philips Medical Systems. The first of this breed of scanner began operating in mid-October at a Las Vegas outpatient clinic owned by Nevada Imaging Centers. It is not the first open 1T to enter clinical service; Siemens Medical Solutions has installed three 1T Rhapsody systems at clinical sites. The Panorama 1T, however, is the only truly high-field open MR designed for mass production. Routine deliveries of the system, which was shown at this year's RSNA meeting, are scheduled to begin in 2005.
The scanner is designed to produce images as good and as fast as those acquired at 1.5T, while offering the patient the benefits of an open design. The actively shielded vertical-field superconducting magnet operates on the same platform as the company's cylindrical Achieva, but it relies on specially designed coils that are more efficient than those for the traditional horizontal cylindrical field systems, according to the company. A wheeled patient table that docks with the scanner boosts throughput: A site purchasing two such tables can use one to prepare a patient while the other is docked to the scanner. (Provided by Philips Medical Solutions)
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
